Many clinical reports have shown that tumor resection surgery combined with p53 gene therapy can reduce the postoperative recurrence or metastasis rate, improve the surgical cure rate, and improve the progression free survival and overall survival of tumor patients [21,66,67], but the relevant mechanisms are not clear. Here, TP53 is linked to neoplasm.